Korean Chinese Japanese
  • Economy
  • Politics
  • Society
  • Securities
  • Real estate
  • Culture
  • Entertainment
  • Sports
  • Opinion
Korean Chinese Japanese
Economy Corporation Pharma & Bio
Society Politics IT·Science
Securities Real Estate Global
Opinion Entertainment Sports Culture
Video Auto in Golf in
PHARM EDAILY Market in TheBeLT
Pharma & Bio
Lifestyle

"Premium" in the U.S. and Europe, "Volume" in Shinhung… Value Added Technology Co., Ltd.’s "Two-Track" Strategy

Value Added Technology Co., Ltd.(043150)is accelerating its global growth through a “dual-track strategy”: raising average selling prices with premium products in developed markets while increasing sa…
  • 2026-09-12 08:11:02
  • Kim Jinsoo
Business·Industry

[Noul Co., Ltd. Deep Seek ③] The Looming Shadow of Another Stock Offering… Year-End Is the Crucial Moment

The shadow of another capital increase is looming over the artificial intelligence (AI) diagnostics company Noul Co., Ltd.(376930). Having raised approximately 25 billion won through a capital increas…
  • 2026-09-12 08:04:02
  • KIM SAE-MI
Technology

Lee Byung-hwan, CEO of SkyLabs: "In Discussions with Otsuka and U.S. Partners… Aiming for FDA Approval Next Year"

#SkyLabs is taking the final steps toward entering the U.S. market.Lee Byung-hwan, CEO of SkyLabs, met with E-Daily on the 7th and stated, “Since the cuffless continuous blood pressure monitor must go…
  • 2026-09-11 11:01:02
  • Kim Seung-kwon
Lifestyle

'Loresibint Under Review for Approval in the U.K. Following U.S. Approval'… SamilPharmaceutical Gets Green Light to Enter 8 Trillion Won Korean Market

SamilPharmaceutical(000520)With “Lorecivivint,” a new drug for osteoarthritis for which BioSplice holds exclusive domestic distribution rights, entering the regulatory review process in the UK followi…
  • 2026-09-11 10:02:02
  • KIM JI-WAN
Technology

Aston Science Makes Another Run at an IPO… October Results for Stomach Cancer Vaccine Will Determine Success or Failure

Aston Science’s cancer vaccine AST-301 (HER2-ICD vaccine) is set to receive its first Phase 2 clinical trial results for stomach cancer this coming October. The company has completed patient recruitme…
  • 2026-09-11 08:46:02
  • NA EUN-KYUNG
Lifestyle

[Exclusive] KMPHARMACEUTICAL Co.,Ltd. Fails to Surpass 20 Billion Won in Market Cap… First Delisting from K-Bio

Following the government’s measures to tighten KOSDAQ delisting requirements, the first delisting case has emerged in the pharmaceutical and biotech industry. KMPHARMACEUTICAL Co.,Ltd., a small but st…
  • 2026-09-11 08:31:02
  • YU JIN-HEE
Lifestyle

Aptabio Therapeutics Inc. Takes a Gamble with APX-115 Package Deal… Next Month Will Be a Turning Point for Its “Valuation”

Aptabio Therapeutics Inc.(293780)is making a bold move with a “package deal” as it pursues the technology export of “APX-115” (Isuzinacxib), a pan-NADPH oxidase (Pan-NOX) inhibitor currently under dev…
  • 2026-09-11 08:17:02
  • Kim Jinsoo
Technology

MGEN Solutions and BLUEMTEC Jump as Investors Watch for Unusual Moves [K-Bio Pulse]

MGEN Solutions, whose shares began rallying before it disclosed a change in management control, and BLUEMTEC, which jumped nearly 12% without any apparent new catalyst, drew market attention on Tuesda…
  • 2026-09-11 07:32:02
  • NA EUN-KYUNG
Technology

MGEN SOLUTIONS Rallies Ahead of Management Control Disclosure… IlyangPharmaceutical Remains Flat Despite Negative News [Bio Market Watch]

On the 9th, in the domestic pharmaceutical, biotech, and healthcare stock market, MGEN SOLUTIONS(032790)—whose stock price had already surged prior to the announcement of a change in management contro…
  • 2026-09-11 07:31:02
  • NA EUN-KYUNG
Technology

Yuhan Corporation’s New Drug, Stalled for Four Years, Seeks Technology Export… “500 Billion Won Jackpot” Opportunity to Be Decided Within a Year

(Graphic: ChatGPT) Yuhan(000100)The fate of the new drug candidate “PCS12852” (Yuhan Corporation’s development code: YH12852), which Yuhan Corporation licensed to U.S.-based Processa Pharmaceutica…
  • 2026-09-10 08:16:04
  • Minji Son
prev 21 22 23 24 25 26 27 28 29 30 next

PHARM EDAILY

Shorts

EDAILY
  • 92, Tongil-ro, Jung-gu, Seoul, Korea
  • +82 2 3772 0114
  • webmaster@edaily.co.kr

※ This article has been translated using AI technology for the convenience of readers.

EDAILY provides this translation on an “as is” basis and makes no warranties, express or implied, regarding its accuracy, reliability, completeness, merchantability, or fitness for a particular purpose.
Due to the limitations of machine translation, the translated content may differ from the original Korean article. In the event of any discrepancy, the original Korean version shall prevail.
EDAILY shall not be liable for any loss or damage arising from the use of, or reliance on, the translated content.

© 2026 Copyrights by edaily. All Rights Reserved.
Korea China Japan
English